A first-in-human, phase I single-arm trial has found that in-utero treatment of myelomeningocele, the most severe form of spina bifida, using allogeneic live stem cells was both feasible and safe.…
New Delhi: Emcure Pharmaceuticals has announced the signing of a distribution agreement with Roche for select products in the nephrology and transplant medicine portfolio, marking a significant step toward expanding…
New Delhi: The Appointments Committee of the Cabinet has cleared yet another extension for Dr Rajeev Singh Raghuvanshi as Drugs Controller (India) at the Central Drugs Standard Control Organisation (CDSCO),…
New Delhi: Cipla Limited has announced that it has entered into a 60:40 joint venture agreement with Kemwell Biopharma Private Limited for incorporation of a new joint venture company in…
A new study published in The New England Journal of Medicine revealed that the antiviral drug tecovirimat did not significantly improve recovery outcomes among adults infected with the clade II…
A new study published in the Journal of the American Medical Association showed that there was a dose-response relationship between the number of pre-existing maternal chronic illnesses and the likelihood…
A recent nationwide retrospective study found that early use of microaxial flow pumps (mAFP) in patients with acute myocardial infarction-related cardiogenic shock (AMI-CS) was associated with a 2.31-fold increase in…
Saudi Arabia: A new study has found that fiber posts demonstrate the most favorable clinical outcomes, primarily by reducing the risk of catastrophic root fractures. In contrast, metallic and custom-made…
Moderna's Covid-19 shot settlement, Prime Medicine's gene therapy, and other biotech news from The Readout
Moderna agreed to pay Roivant up to $2.25 billion to settle claims that its mRNA Covid vaccine infringed on Roivant’s patents